DXM Abuse Prevention Act of 2019
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
Referred to the House Committee on Energy and Commerce.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 863: DXM Abuse Prevention Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-863/
"H.R. 863: DXM Abuse Prevention Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-863/.
H.R. 863, 116th Cong. (2026), https://openamerica.io/bill/116-HR-863/.
[H.R. 863: DXM Abuse Prevention Act of 2019](https://openamerica.io/bill/116-HR-863/)